Last 12 months
Inside the activity.
0 purchase rows · 20 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 7 |
| Mar 2026 | 0 | 3 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 0 | 5 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 12, 2019 Filed Feb 14, 2019 21:33 UTC |
Gilliland Dwight GaryDirector
|
GrantRestricted Stock Unit · Derivative | 1,227 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006008 · form4.xml · derivative · entry 3 Gilliland Dwight Gary · CIK 0001603769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,227 Underlying: Common Stock · 1,227 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vest fully on February 12, 2020. F3 · derivative.expiration_date: The Restricted Stock Units vest fully on February 12, 2020. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:33 UTC |
Gilliland Dwight GaryDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,038 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006008 · form4.xml · derivative · entry 2 Gilliland Dwight Gary · CIK 0001603769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,038 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vested fully on February 12, 2019. F2 · derivative.expiration_date: The Restricted Stock Units vested fully on February 12, 2019. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:33 UTC |
Gilliland Dwight GaryDirector
|
Exercise / conversionCommon Stock | 1,038 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-006008 · form4.xml · nonDerivative · entry 1 Gilliland Dwight Gary · CIK 0001603769 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,539 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:30 UTC |
ANDERSON KERRII BDirector
|
GrantRestricted Stock Unit · Derivative | 1,227 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006006 · form4.xml · derivative · entry 3 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,227 Underlying: Common Stock · 1,227 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vest fully on February 12, 2020. F3 · derivative.expiration_date: The Restricted Stock Units vest fully on February 12, 2020. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:30 UTC |
ANDERSON KERRII BDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,038 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006006 · form4.xml · derivative · entry 2 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,038 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vested fully on February 12, 2019. F2 · derivative.expiration_date: The Restricted Stock Units vested fully on February 12, 2019. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:30 UTC |
ANDERSON KERRII BDirector
|
Exercise / conversionCommon Stock | 1,038 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-006006 · form4.xml · nonDerivative · entry 1 ANDERSON KERRII B · CIK 0001227159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,133 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:27 UTC |
Kong GarhengDirector
|
GrantRestricted Stock Unit · Derivative | 1,227 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006004 · form4.xml · derivative · entry 3 Kong Garheng · CIK 0001435183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,227 Underlying: Common Stock · 1,227 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vest fully on February 12, 2020. F3 · derivative.expiration_date: The Restricted Stock Units vest fully on February 12, 2020. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:27 UTC |
Kong GarhengDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,038 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006004 · form4.xml · derivative · entry 2 Kong Garheng · CIK 0001435183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,038 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vested fully on February 12, 2019. F2 · derivative.expiration_date: The Restricted Stock Units vested fully on February 12, 2019. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:27 UTC |
Kong GarhengDirector
|
Exercise / conversionCommon Stock | 1,038 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-006004 · form4.xml · nonDerivative · entry 1 Kong Garheng · CIK 0001435183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,225 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:26 UTC |
Parham Richelle PDirector
|
GrantRestricted Stock Unit · Derivative | 1,227 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006003 · form4.xml · derivative · entry 3 Parham Richelle P · CIK 0001550078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,227 Underlying: Common Stock · 1,227 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vest fully on February 12, 2020. F3 · derivative.expiration_date: The Restricted Stock Units vest fully on February 12, 2020. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:26 UTC |
Parham Richelle PDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,038 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006003 · form4.xml · derivative · entry 2 Parham Richelle P · CIK 0001550078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,038 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vested fully on February 12, 2019. F2 · derivative.expiration_date: The Restricted Stock Units vested fully on February 12, 2019. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:26 UTC |
Parham Richelle PDirector
|
Exercise / conversionCommon Stock | 1,038 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-006003 · form4.xml · nonDerivative · entry 1 Parham Richelle P · CIK 0001550078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,861 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:25 UTC |
MITTELSTAEDT ROBERT E JRDirector
|
GrantRestricted Stock Unit · Derivative | 306 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006001 · form4.xml · derivative · entry 3 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306 Underlying: Common Stock · 306 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vest fully on February 12, 2020. F3 · derivative.expiration_date: The Restricted Stock Units vest fully on February 12, 2020. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:25 UTC |
MITTELSTAEDT ROBERT E JRDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,038 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-006001 · form4.xml · derivative · entry 2 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,038 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F2 · derivative.exercise_date: The Restricted Stock Units vested fully on February 12, 2019. F2 · derivative.expiration_date: The Restricted Stock Units vested fully on February 12, 2019. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:25 UTC |
MITTELSTAEDT ROBERT E JRDirector
|
Exercise / conversionCommon Stock | 1,038 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-006001 · form4.xml · nonDerivative · entry 1 MITTELSTAEDT ROBERT E JR · CIK 0001200847 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,209 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:18 UTC |
Williams R SandersDirector
|
GrantRestricted Stock Unit · Derivative | 1,227 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-005996 · form4.xml · derivative · entry 4 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,227 Underlying: Common Stock · 1,227 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units vest fully on February 12, 2020. F4 · derivative.expiration_date: The Restricted Stock Units vest fully on February 12, 2020. F5 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:18 UTC |
Williams R SandersDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,038 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-005996 · form4.xml · derivative · entry 3 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,038 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vested fully on February 12, 2019. F3 · derivative.expiration_date: The Restricted Stock Units vested fully on February 12, 2019. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:18 UTC |
Williams R SandersDirector
|
Exercise / conversionCommon Stock | 1,038 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-005996 · form4.xml · nonDerivative · entry 1 Williams R Sanders · CIK 0001375347 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,924 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:13 UTC |
Dodson Edward TPrincipal Accounting Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 196 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-005993 · form4.xml · derivative · entry 3 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 641 Underlying: Common Stock · 196 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on 2/12/19. F3 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on 2/12/19. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:13 UTC |
Dodson Edward TPrincipal Accounting Officer
|
Tax withholdingCommon Stock | 54 | $146.59 | $7,915.86 |
DisclosureSEC source: 0001127602-19-005993 · form4.xml · nonDerivative · entry 2 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,911.9335 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:13 UTC |
Dodson Edward TPrincipal Accounting Officer
|
Exercise / conversionCommon Stock | 196 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-005993 · form4.xml · nonDerivative · entry 1 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,965.9335 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:10 UTC |
EBERTS F SAMUEL IIIChief Legal Officer, Secretary
|
Exercise / conversionRestricted Stock Unit · Derivative | 233 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-005988 · form4.xml · derivative · entry 3 EBERTS F SAMUEL III · CIK 0001229291 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 764 Underlying: Common Stock · 233 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on 2/12/19. F3 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on 2/12/19. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:10 UTC |
EBERTS F SAMUEL IIIChief Legal Officer, Secretary
|
Tax withholdingCommon Stock | 64 | $146.59 | $9,381.76 |
DisclosureSEC source: 0001127602-19-005988 · form4.xml · nonDerivative · entry 2 EBERTS F SAMUEL III · CIK 0001229291 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,823 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:10 UTC |
EBERTS F SAMUEL IIIChief Legal Officer, Secretary
|
Exercise / conversionCommon Stock | 233 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-005988 · form4.xml · nonDerivative · entry 1 EBERTS F SAMUEL III · CIK 0001229291 · Chief Legal Officer, Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,887 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:08 UTC |
Ratliff John DCEO, Covance Drug Development
|
GrantNon-qualified Stock Options · Derivative | 21,800 | $0.00 Strike: $146.59 | $0.00 |
DisclosureSEC source: 0001127602-19-005984 · form4.xml · derivative · entry 7 Ratliff John D · CIK 0001575951 · CEO, Covance Drug Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,800 Underlying: Common Stock · 21,800 shares Expires 2029-02-11 F7 · security: Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan. F8 · derivative.exercise_date: The option vests in three equal installments beginning on the date reflected in this column. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:08 UTC |
Ratliff John DCEO, Covance Drug Development
|
GrantRestricted Stock Unit · Derivative | 5,300 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-005984 · form4.xml · derivative · entry 6 Ratliff John D · CIK 0001575951 · CEO, Covance Drug Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,211 Underlying: Common Stock · 5,300 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F6 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/12/2020. F6 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/12/2020. F5 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:08 UTC |
Ratliff John DCEO, Covance Drug Development
|
Exercise / conversionRestricted Stock Unit · Derivative | 1,463 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-005984 · form4.xml · derivative · entry 5 Ratliff John D · CIK 0001575951 · CEO, Covance Drug Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,911 Underlying: Common Stock · 1,463 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F4 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on 2/12/19. F4 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on 2/12/19. F5 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:08 UTC |
Ratliff John DCEO, Covance Drug Development
|
Tax withholdingCommon Stock | 654 | $146.59 | $95,869.86 |
DisclosureSEC source: 0001127602-19-005984 · form4.xml · nonDerivative · entry 2 Ratliff John D · CIK 0001575951 · CEO, Covance Drug Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,601 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:08 UTC |
Ratliff John DCEO, Covance Drug Development
|
Exercise / conversionCommon Stock | 1,463 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-005984 · form4.xml · nonDerivative · entry 1 Ratliff John D · CIK 0001575951 · CEO, Covance Drug Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,255 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:02 UTC |
BERBERIAN LANCESVP, Chief Information Officer
|
GrantNon-qualified Stock Options · Derivative | 4,400 | $0.00 Strike: $146.59 | $0.00 |
DisclosureSEC source: 0001127602-19-005976 · form4.xml · derivative · entry 6 BERBERIAN LANCE · CIK 0001102900 · SVP, Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,400 Underlying: Common Stock · 4,400 shares Expires 2029-02-11 F6 · security: Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan. F7 · derivative.exercise_date: The option vests in three equal installments beginning on the date reflected in this column. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:02 UTC |
BERBERIAN LANCESVP, Chief Information Officer
|
GrantRestricted Stock Unit · Derivative | 7,060 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-005976 · form4.xml · derivative · entry 5 BERBERIAN LANCE · CIK 0001102900 · SVP, Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,884 Underlying: Common Stock · 7,060 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F5 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/12/2020. F5 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/12/2020. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:02 UTC |
BERBERIAN LANCESVP, Chief Information Officer
|
GrantRestricted Stock Unit · Derivative | 1,060 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-005976 · form4.xml · derivative · entry 4 BERBERIAN LANCE · CIK 0001102900 · SVP, Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,824 Underlying: Common Stock · 1,060 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F5 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/12/2020. F5 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/12/2020. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:02 UTC |
BERBERIAN LANCESVP, Chief Information Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 233 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-005976 · form4.xml · derivative · entry 3 BERBERIAN LANCE · CIK 0001102900 · SVP, Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 764 Underlying: Common Stock · 233 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on 2/12/19. F3 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on 2/12/19. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:02 UTC |
BERBERIAN LANCESVP, Chief Information Officer
|
Tax withholdingCommon Stock | 70 | $146.59 | $10,261.30 |
DisclosureSEC source: 0001127602-19-005976 · form4.xml · nonDerivative · entry 2 BERBERIAN LANCE · CIK 0001102900 · SVP, Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,756 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 21:02 UTC |
BERBERIAN LANCESVP, Chief Information Officer
|
Exercise / conversionCommon Stock | 233 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-005976 · form4.xml · nonDerivative · entry 1 BERBERIAN LANCE · CIK 0001102900 · SVP, Chief Information Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,826 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 20:59 UTC |
Caveney Brian JSVP, Chief Medical Officer
|
GrantNon-qualified Stock Options · Derivative | 3,500 | $0.00 Strike: $146.59 | $0.00 |
DisclosureSEC source: 0001127602-19-005975 · form4.xml · derivative · entry 6 Caveney Brian J · CIK 0001717915 · SVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,500 Underlying: Common Stock · 3,500 shares Expires 2029-02-11 F6 · security: Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan. F7 · derivative.exercise_date: The option vests in three equal installments beginning on the date reflected in this column. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 20:59 UTC |
Caveney Brian JSVP, Chief Medical Officer
|
GrantRestricted Stock Unit · Derivative | 7,060 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-005975 · form4.xml · derivative · entry 5 Caveney Brian J · CIK 0001717915 · SVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,347 Underlying: Common Stock · 7,060 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F5 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/12/2020. F5 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/12/2020. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 20:59 UTC |
Caveney Brian JSVP, Chief Medical Officer
|
GrantRestricted Stock Unit · Derivative | 850 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-005975 · form4.xml · derivative · entry 4 Caveney Brian J · CIK 0001717915 · SVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,287 Underlying: Common Stock · 850 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F5 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/12/2020. F5 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/12/2020. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 20:59 UTC |
Caveney Brian JSVP, Chief Medical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 233 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-005975 · form4.xml · derivative · entry 3 Caveney Brian J · CIK 0001717915 · SVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,437 Underlying: Common Stock · 233 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on 2/12/19. F3 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on 2/12/19. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 20:59 UTC |
Caveney Brian JSVP, Chief Medical Officer
|
Tax withholdingCommon Stock | 82 | $146.59 | $12,020.38 |
DisclosureSEC source: 0001127602-19-005975 · form4.xml · nonDerivative · entry 2 Caveney Brian J · CIK 0001717915 · SVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 20:59 UTC |
Caveney Brian JSVP, Chief Medical Officer
|
Exercise / conversionCommon Stock | 233 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-005975 · form4.xml · nonDerivative · entry 1 Caveney Brian J · CIK 0001717915 · SVP, Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 233 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 20:58 UTC |
Uthgenannt Lisa JChief Human Resources Officer
|
GrantNon-qualified Stock Options · Derivative | 3,800 | $0.00 Strike: $146.59 | $0.00 |
DisclosureSEC source: 0001127602-19-005974 · form4.xml · derivative · entry 5 Uthgenannt Lisa J · CIK 0001636456 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,800 Underlying: Common Stock · 3,800 shares Expires 2029-02-11 F6 · security: Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan. F7 · derivative.exercise_date: The option vests in three equal installments beginning on the date reflected in this column. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 20:58 UTC |
Uthgenannt Lisa JChief Human Resources Officer
|
GrantRestricted Stock Unit · Derivative | 930 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-005974 · form4.xml · derivative · entry 4 Uthgenannt Lisa J · CIK 0001636456 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,771 Underlying: Common Stock · 930 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F5 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/12/2020. F5 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on 2/12/2020. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 20:58 UTC |
Uthgenannt Lisa JChief Human Resources Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 256 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-005974 · form4.xml · derivative · entry 3 Uthgenannt Lisa J · CIK 0001636456 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 841 Underlying: Common Stock · 256 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on 2/12/19. F3 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on 2/12/19. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 20:58 UTC |
Uthgenannt Lisa JChief Human Resources Officer
|
Tax withholdingCommon Stock | 103 | $146.59 | $15,098.77 |
DisclosureSEC source: 0001127602-19-005974 · form4.xml · nonDerivative · entry 2 Uthgenannt Lisa J · CIK 0001636456 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,489.0782 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 12, 2019 Filed Feb 14, 2019 20:58 UTC |
Uthgenannt Lisa JChief Human Resources Officer
|
Exercise / conversionCommon Stock | 256 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-005974 · form4.xml · nonDerivative · entry 1 Uthgenannt Lisa J · CIK 0001636456 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,592.0782 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 17:22 UTC |
Uthgenannt Lisa JChief Human Resources Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 604 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-005563 · form4.xml · derivative · entry 3 Uthgenannt Lisa J · CIK 0001636456 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,097 Underlying: Common Stock · 604 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vested in three equal installments beginning on 2/9/2017 and are now fully vested. F3 · derivative.expiration_date: The Restricted Stock Units vested in three equal installments beginning on 2/9/2017 and are now fully vested. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 17:22 UTC |
Uthgenannt Lisa JChief Human Resources Officer
|
Tax withholdingCommon Stock | 240 | $144.29 | $34,629.60 |
DisclosureSEC source: 0001127602-19-005563 · form4.xml · nonDerivative · entry 2 Uthgenannt Lisa J · CIK 0001636456 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,336.0782 F2 · kind: Stock withholding to satisfy tax withholding obligations. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 17:22 UTC |
Uthgenannt Lisa JChief Human Resources Officer
|
Exercise / conversionCommon Stock | 604 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-19-005563 · form4.xml · nonDerivative · entry 1 Uthgenannt Lisa J · CIK 0001636456 · Chief Human Resources Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,576.0782 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 17:18 UTC |
Dodson Edward TPrincipal Accounting Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 450 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-005562 · form4.xml · derivative · entry 3 Dodson Edward T · CIK 0001620889 · Principal Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 837 Underlying: Common Stock · 450 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock. F3 · derivative.exercise_date: The Restricted Stock Units vested in three equal annual installments beginning on 2/9/17 and are now fully vested. F3 · derivative.expiration_date: The Restricted Stock Units vested in three equal annual installments beginning on 2/9/17 and are now fully vested. F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.